PortfoliosLab logoPortfoliosLab logo
Alumis Inc (ALMS)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US0223071020
IPO Date
Jun 28, 2024

Highlights

EPS (TTM)
-$2.71
Total Revenue (TTM)
$22.12M
Gross Profit (TTM)
$21.30M
EBITDA (TTM)
-$424.43M
Year Range
$2.76 - $30.60
Target Price
$38.44
ROA (TTM)
-59.51%
ROE (TTM)
-81.37%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Alumis Inc

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Alumis Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Alumis Inc (ALMS) has returned 125.72% so far this year and 258.79% over the past 12 months.


Alumis Inc

1D
9.01%
1M
-25.80%
YTD
125.72%
6M
452.13%
1Y
258.79%
3Y*
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jun 28, 2024, ALMS's average daily return is +0.36%, while the average monthly return is +8.09%. At this rate, your investment would double in approximately 0.7 years.

Historically, 48% of months were positive and 52% were negative. The best month was Jan 2026 with a return of +151.1%, while the worst month was Feb 2025 at -37.8%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 4 months.

On a daily basis, ALMS closed higher 48% of trading days. The best single day was Jan 6, 2026 with a return of +95.3%, while the worst single day was Apr 8, 2025 at -26.5%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026151.13%21.13%-25.80%125.72%
2025-4.83%-37.83%32.04%-32.57%-15.46%-14.29%38.00%12.08%-14.01%19.05%61.47%27.25%24.17%
2024-7.52%3.25%-15.91%5.99%-18.20%-15.12%-40.90%

Benchmark Metrics

Alumis Inc has an annualized alpha of 126.94%, beta of 0.83, and R² of 0.01 versus S&P 500 Index. Calculated based on daily prices since July 01, 2024.

  • This stock captured 430.64% of S&P 500 Index gains and 243.31% of its losses — amplifying both gains and losses, but participating more in upside than downside.
  • R² of 0.01 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
126.94%
Beta
0.83
0.01
Upside Capture
430.64%
Downside Capture
243.31%

Return for Risk

Risk / Return Rank

ALMS ranks 89 for risk / return — in the top 89% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.


ALMS Risk / Return Rank: 8989
Overall Rank
ALMS Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
ALMS Sortino Ratio Rank: 9393
Sortino Ratio Rank
ALMS Omega Ratio Rank: 9292
Omega Ratio Rank
ALMS Calmar Ratio Rank: 9090
Calmar Ratio Rank
ALMS Martin Ratio Rank: 8181
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Alumis Inc (ALMS) and compare them to a chosen benchmark (S&P 500 Index).


ALMSBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

1.84

0.90

+0.95

Sortino ratio

Return per unit of downside risk

3.28

1.39

+1.89

Omega ratio

Gain probability vs. loss probability

1.43

1.21

+0.22

Calmar ratio

Return relative to maximum drawdown

4.03

1.40

+2.63

Martin ratio

Return relative to average drawdown

6.31

6.61

-0.29

Explore ALMS risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Alumis Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Alumis Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Alumis Inc was 78.95%, occurring on Jun 23, 2025. Recovery took 136 trading sessions.

The current Alumis Inc drawdown is 26.52%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-78.95%Jul 1, 2024245Jun 23, 2025136Jan 6, 2026381
-32.59%Feb 27, 202622Mar 30, 2026
-11.55%Jan 29, 20262Jan 30, 202613Feb 19, 202615
-8.1%Jan 22, 20262Jan 23, 20263Jan 28, 20265
-5.32%Feb 20, 20262Feb 23, 20262Feb 25, 20264

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Alumis Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Alumis Inc is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ALMS relative to other companies in the Biotechnology industry. Currently, ALMS has a P/S ratio of 90.0. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items